Association of serum calcium with serum sex steroid hormones in men in NHANES III

References

• Gao X, LaValley MP, Tucker KL. Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst 2005;97:1768–77
   PubMed Web of Science ®Google Scholar
• Ma RW, Chapman K. A systematic review of the effect of diet in prostate cancer prevention and treatment. J Hum Nutr Diet 2009;22:187–99
   PubMed Web of Science ®Google Scholar
• Halthur C, Johansson AL, Almquist M, et al. Serum calcium and the risk of prostate cancer. Cancer Causes Control 2009;20:1205–14
   PubMed Web of Science ®Google Scholar
• Skinner HG, Schwartz GG. Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 2008;17:2302–5
   PubMed Web of Science ®Google Scholar
• Skinner HG, Schwartz GG. The relation of serum parathyroid hormone and serum calcium to serum levels of prostate-specific antigen: a population-based study. Cancer Epidemiol Biomarkers Prev 2009;18:2869–73
   PubMed Web of Science ®Google Scholar
• Skinner HG, Schwartz GG. A prospective study of total and ionized serum calcium and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 2009;18:575–8
   PubMed Web of Science ®Google Scholar
• Van Hemelrijck M, Hermans R, Michaelsson K, et al. Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study. Cancer Causes Control 2012;23:1349--58
   PubMed Web of Science ®Google Scholar
• Van Hemelrijck M, Hermans R, Michaelsson K, et al. Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study. Cancer Causes Control 2012;23:1349–58
   PubMed Web of Science ®Google Scholar
• Ray R, Banks M, Abuzahra H, et al. Effect of dietary vitamin D and calcium on the growth of androgen-insensitive human prostate tumor in a murine model. Anticancer Res 2012;32:727–31
   PubMed Web of Science ®Google Scholar
• Bruno RD, Gover TD, Burger AM, et al. 17Alpha-hydroxylase/17,20 lyase inhibitor VN/124-1 inhibits growth of androgen-independent prostate cancer cells via induction of the endoplasmic reticulum stress response. Mol Cancer Ther 2008;7:2828–36
   PubMed Web of Science ®Google Scholar
• Oury F, Sumara G, Sumara O, et al. Endocrine regulation of male fertility by the skeleton. Cell. 2011;144:796–809
   PubMed Web of Science ®Google Scholar
• Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Front Biosci 2006;11:1388–413
   PubMed Web of Science ®Google Scholar
• Huggins C, Hodges CV. Studies on prostatic cancer – I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 1972;22:232–40
   PubMedGoogle Scholar
• Richter E, Srivastava S, Dobi A. Androgen receptor and prostate cancer. Prostate Cancer Prostatic Dis 2007;10:114–8
   PubMed Web of Science ®Google Scholar
• Berry PA, Birnie R, Droop AP, et al. The calcium sensor STIM1 is regulated by androgens in prostate stromal cells. Prostate 2011;71:1646–55
   PubMed Web of Science ®Google Scholar
• Szendroi A, Speer G, Tabak A, et al. The role of vitamin D, estrogen, calcium sensing receptor genotypes and serum calcium in the pathogenesis of prostate cancer. Can J Urol 2011;18:5710–6
   PubMed Web of Science ®Google Scholar
• Leclercq G. Calcium-induced activation of estrogen receptor alpha – new insight. Steroids 2012;77:924–7
   PubMed Web of Science ®Google Scholar
• National Center for Health Statistics. Plan and operation of the third national health and nutrition examination survey, 1988–94. Series 1: programs and collection procedures. Vital Health Stat 1 1994:1–407
   Google Scholar
• Rohrmann S, Nelson WG, Rifai N, et al. Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans. J Clin Endocrinol Metab 2007;92:2519–25
   PubMed Web of Science ®Google Scholar
• Rinaldi S, Geay A, Dechaud H, et al. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev 2002;11:1065–71
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666–72
   PubMed Web of Science ®Google Scholar
• Chumlea WC, Guo SS, Kuczmarski RJ, et al. Body composition estimates from NHANES III bioelectrical impedance data. Int J Obes Relat Metab Disord 2002;26:1596–609
   PubMed Web of Science ®Google Scholar
• Sabanayagam C, Shankar A. Serum calcium levels and hypertension among U.S. adults. J Clin Hypertens (Greenwich) 2011;13:716–21
   PubMed Web of Science ®Google Scholar
• Shiels MS, Rohrmann S, Menke A, et al. Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men. Cancer Causes Control 2009;20:877–86
   PubMed Web of Science ®Google Scholar
• Bringhurst F, Demay M, Krane S, Kronenberg H. Bone and mineral metabolism in health and disease. In: Fauci A, Longo D, Kasper D, et al., eds. Harrison's principles of internal medicine. Chap. 352. New York: McGraw-Hill; 2008
   Google Scholar
• Goldfarb-Rumyantzev AS, Rout P, Sandhu GS, et al. Association between social adaptability index and survival of patients with chronic kidney disease. Nephrol Dial Transplant 2010;25:3672–81
   PubMed Web of Science ®Google Scholar
• Brandstedt J, Almquist M, Manjer J, Malm J. Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case-control study. Cancer Causes Control 2012;23:1377–85
   PubMed Web of Science ®Google Scholar
• Shui IM, Mucci LA, Kraft P, et al. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst 2012;104:690–9
   PubMed Web of Science ®Google Scholar
• Michaelsson K, Baron JA, Snellman G, et al. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 2010;92:841–8
   PubMed Web of Science ®Google Scholar
• Blomberg Jensen M. Vitamin D metabolism, sex hormones and male reproductive function. Reproduction 2012;77:903–9
   Google Scholar
• Alexandre C. Androgens and bone metabolism. Joint Bone Spine 2005;72:202–6
   PubMed Web of Science ®Google Scholar
• Massie CE, Lynch A, Ramos-Montoya A, et al. The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J 2011;30:2719–33
   PubMed Web of Science ®Google Scholar
• Roder MA, Christensen IJ, Berg KD, et al. Serum testosterone level as a predictor of biochemical failure after radical prostatectomy for localized prostate cancer. BJU Int 2012;109:520–4
   PubMed Web of Science ®Google Scholar
• Goldenberg SL, Koupparis A, Robinson ME. Differing levels of testosterone and the prostate: a physiological interplay. Nat Rev Urol 2011;8:365–77
   PubMed Web of Science ®Google Scholar
• Salonia A, Gallina A, Briganti A, et al. Circulating estradiol, but not testosterone, is a significant predictor of high-grade prostate cancer in patients undergoing radical prostatectomy. Cancer 2011;117:5029–38
   PubMed Web of Science ®Google Scholar
• Hyde Z, Flicker L, McCaul KA, et al. Associations between testosterone levels and incident prostate, lung, and colorectal cancer. A population-based study. Cancer Epidemiol Biomarkers Prev 2012;21:1319–29
   PubMed Web of Science ®Google Scholar
• Waldert M, Schatzl G, Swietek N, et al. Sex hormone-binding globulin is an independent predictor of biochemical recurrence after radical prostatectomy. J Urol 2012;188:792–7
   PubMed Web of Science ®Google Scholar
• Roddam AW, Allen NE, Appleby P, Key TJ. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 2008;100:170–83
   PubMed Web of Science ®Google Scholar
• Thorstenson A, Bratt O, Akre O, et al. Incidence of fractures causing hospitalisation in prostate cancer patients: results from the population-based PCBaSe Sweden. Eur J Cancer 2012;48:1672–81
   PubMed Web of Science ®Google Scholar
• Petrylak DP, Moul JW. Androgen abliation for prostate cancer: mechanisms and modalities. In: Kantoff PC, Carroll PR, D'Amico AV, eds. Prostate cancer: principles and practice. Philadelphia: Lippincott Williams & Wilkins; 2002:518–23
   Google Scholar
• Hakimian P, Blute M Jr, Kashanian J, et al. Metabolic and cardiovascular effects of androgen deprivation therapy. BJU Int 2008;102:1509–14
   PubMed Web of Science ®Google Scholar
• Sprenkle PC, Fisch H. Pathologic effects of testosterone deprivation. Curr Opin Urol 2007;17:424–30
   PubMed Web of Science ®Google Scholar
• Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 2005;352:154–64
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Laughlin G, Li H, et al. The association of concurrent vitamin D and sex hormone deficiency with bone loss and fracture risk in older men: the MrOS study. J Bone Miner Res 2012;27:2306–13
   PubMed Web of Science ®Google Scholar